Bullish option flow detected in Crispr Therapeutics with 2,642 calls trading, 1.3x expected, and implied vol increasing almost 2 points to 50.18%. Jun-24 50 calls and Jun-24 65 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.41. Earnings are expected on August 5th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Crispr Therapeutics AG Advances Governance and Incentives
- CRISPR Therapeutics to Participate in Upcoming Investor Conferences
- Crispr Therapeutics appoints Patel as CMO, Bruno as COO
- Crispr Therapeutics price target lowered to $84 from $89 at Citi
- Cathie Wood’s ARK Investment bought 86.9K shares of Crispr Therapeutics today